Ning Lou

836 total citations
37 papers, 630 citations indexed

About

Ning Lou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ning Lou has authored 37 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Ning Lou's work include Renal and related cancers (7 papers), Renal cell carcinoma treatment (5 papers) and Ferroptosis and cancer prognosis (5 papers). Ning Lou is often cited by papers focused on Renal and related cancers (7 papers), Renal cell carcinoma treatment (5 papers) and Ferroptosis and cancer prognosis (5 papers). Ning Lou collaborates with scholars based in China and United States. Ning Lou's co-authors include Xiaoping Zhang, Hongmei Yang, Hailong Ruan, Wenjun Hu, Bin Qiu, Yali Zhou, Wen Xiao, Weiwei Han, Ke Chen and Anming Ruan and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Immunology and American Journal of Physiology-Cell Physiology.

In The Last Decade

Ning Lou

35 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Lou China 16 392 273 141 118 74 37 630
Nayara Izabel Viana Brazil 16 420 1.1× 394 1.4× 175 1.2× 142 1.2× 63 0.9× 64 752
Facai Zhang China 15 214 0.5× 193 0.7× 177 1.3× 77 0.7× 58 0.8× 27 444
Qiuxia Cui China 17 414 1.1× 213 0.8× 190 1.3× 153 1.3× 91 1.2× 38 807
Helin Feng China 15 238 0.6× 197 0.7× 144 1.0× 130 1.1× 44 0.6× 47 557
Monika Migdalska‐Sęk Poland 17 265 0.7× 154 0.6× 125 0.9× 142 1.2× 127 1.7× 47 616
Hongjun Zhao China 14 314 0.8× 151 0.6× 77 0.5× 81 0.7× 152 2.1× 47 615
Tianbo Jin China 15 301 0.8× 137 0.5× 55 0.4× 77 0.7× 76 1.0× 48 522
Shencun Fang China 14 331 0.8× 201 0.7× 374 2.7× 90 0.8× 88 1.2× 40 731
Juanjie Bo China 14 375 1.0× 200 0.7× 120 0.9× 176 1.5× 138 1.9× 24 679

Countries citing papers authored by Ning Lou

Since Specialization
Citations

This map shows the geographic impact of Ning Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Lou more than expected).

Fields of papers citing papers by Ning Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Lou. The network helps show where Ning Lou may publish in the future.

Co-authorship network of co-authors of Ning Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Lou. A scholar is included among the top collaborators of Ning Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Lou. Ning Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Juan, Yang Li, Yingru Liu, et al.. (2025). Comprehensive single-cell analysis deciphered the immunoregulatory mechanism of TPPU in alleviating sepsis-related acute liver injury. Journal of Advanced Research. 71. 457–470. 1 indexed citations
2.
Fu, Li, et al.. (2025). Current research of the Notch pathway in hepatocellular carcinoma. European journal of medical research. 30(1). 402–402.
3.
Lou, Ning, et al.. (2024). Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI. Scientific Data. 11(1). 1369–1369. 2 indexed citations
4.
Lou, Ning, Xinyu Gu, Li Fu, Juan Li, & Chen Xue. (2024). Significant roles of RNA 5-methylcytosine methylation in cancer. Cellular Signalling. 126. 111529–111529. 4 indexed citations
5.
Wang, Shasha, Xuezhi Hao, Liyuan Dai, et al.. (2024). Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy. Lung Cancer. 189. 107503–107503. 3 indexed citations
6.
Liu, Yingru, et al.. (2024). Notch signaling in digestive system cancers: Roles and therapeutic prospects. Cellular Signalling. 124. 111476–111476. 4 indexed citations
7.
Song, Zhengshuai, Qi Cao, Bin Guo, et al.. (2023). Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression. Aging and Disease. 14(5). 1757–1757. 22 indexed citations
8.
Wang, Xuegang, Weiquan Li, Ning Lou, et al.. (2023). High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma. Pharmacogenomics and Personalized Medicine. Volume 16. 1–14. 2 indexed citations
9.
Yuan, Hongwei, Weiquan Li, Ning Lou, et al.. (2022). TRPM2 facilitates tumor progression of clear cell renal cell carcinoma by relieving Endoplasmic Reticulum Stress. International Journal of Medical Sciences. 20(1). 57–69. 5 indexed citations
10.
Xu, Guang‐Hua, Ning Lou, Hangchuan Shi, et al.. (2018). Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. BMC Cancer. 18(1). 88–88. 45 indexed citations
11.
Zhou, Yali, Yan Zhao, Wenjun Hu, et al.. (2017). Hepatitis C virus NS3 protein enhances hepatocellular carcinoma cell invasion by promoting PPM1A ubiquitination and degradation. Journal of Experimental & Clinical Cancer Research. 36(1). 42–42. 28 indexed citations
12.
Ruan, Hailong, Hongmei Yang, Haibin Wei, et al.. (2017). Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition. International Journal of Oncology. 51(1). 336–346. 36 indexed citations
13.
Xiao, Wen, Ning Lou, Hailong Ruan, et al.. (2017). Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A. Cellular Physiology and Biochemistry. 43(6). 2420–2433. 79 indexed citations
14.
Lou, Ning, et al.. (2016). The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2). Molecular Immunology. 81. 59–66. 33 indexed citations
15.
Lü, Xing, Wenjun Hu, Ning Lou, et al.. (2016). Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models. Oncology Reports. 36(6). 3291–3302. 15 indexed citations
16.
Lou, Ning, Anming Ruan, Bin Qiu, et al.. (2016). miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 35(1). 36.e7–36.e14. 45 indexed citations
17.
18.
Chen, Xuanyu, Anming Ruan, Xuegang Wang, et al.. (2014). miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. Journal of Cancer Research and Clinical Oncology. 140(8). 1295–1304. 64 indexed citations
19.
Liu, Xiao, et al.. (2014). Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia. Leukemia & lymphoma. 56(1). 85–91. 17 indexed citations
20.
Wang, Daofeng, Ning Lou, Miao‐Zhen Qiu, Yongbin Lin, & Ying Liang. (2013). Effects of CXCR4 gene silencing by lentivirus shRNA on proliferation of the EC9706 human esophageal carcinoma cell line. Tumor Biology. 34(5). 2951–2959. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nayara Izabel Viana Breakdown of academic impact, for papers by Facai Zhang Breakdown of academic impact, for papers by Qiuxia Cui Breakdown of academic impact, for papers by Helin Feng Breakdown of academic impact, for papers by Monika Migdalska‐Sęk Breakdown of academic impact, for papers by Hongjun Zhao Breakdown of academic impact, for papers by Tianbo Jin Breakdown of academic impact, for papers by Shencun Fang Breakdown of academic impact, for papers by Juanjie Bo
Rankless by CCL
2026